Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05923749 · ClinicalTrials.gov registry record · NA

A RCT Evaluating the Clinical Benefit of a Silver Dressing in the Treatment of Venous Leg Ulcers

A NA study, sponsored by Coloplast A/S.

Completed
Registry status
NA
Development phase
180
Enrollment target

NCT05923749: Completed NA study, sponsored by Coloplast A/S.

NCT05923749 is a NA study that has completed, run by Coloplast A/S. The registered enrollment target is 180 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05923749, a NA study, has completed, sponsored by Coloplast A/S.

COMPLETED
Registry status
NA
Development phase
180 participants
Enrollment target

Study Summary

Approximately 178 patients with a venous leg ulcer will be included in the investigation evaluating wound healing. All subjects are randomized to one of two treatment arms with an intervention period of 4 weeks followed by a 8 week standard of care period.

Primary Outcome

Relative wound area change measured by calculation of area based on photo of wound

Interventions

  • DEVICE Biatain Ag
  • DEVICE Cutimed Siltec Sorbact

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2023-06-29
Est. Completion 2025-01-29
Phase NA
Coloplast A/S

21 total trials

What the finished NCT05923749 record still lists

NCT05923749 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).

The record links to 0 conditions, and to 2 interventions - of which Biatain Ag is the first listed.

NCT05923749 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05923749 about?

NCT05923749 is a clinical study titled "A RCT Evaluating the Clinical Benefit of a Silver Dressing in the Treatment of Venous Leg Ulcers". Approximately 178 patients with a venous leg ulcer will be included in the investigation evaluating wound healing. All subjects are randomized to one of two treatment arms with an intervention period of 4 weeks followed by a 8 week standard of care period.

What is the current status of trial NCT05923749?

This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2023-06-29. Estimated completion is 2025-01-29.

What interventions are being tested in trial NCT05923749?

The interventions under investigation include: Biatain Ag (DEVICE), Cutimed Siltec Sorbact (DEVICE).

Who is sponsoring clinical trial NCT05923749?

This trial is sponsored by Coloplast A/S, which has 21 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05923749's enrollment target sits among peer trials

180 586th of 2000 higher than 1,397 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01558804 · 180 participants

    GRoup A StrePtococcus

  • NCT02932176 · 180 participants

    Machine Learning for Handheld Vascular Studies

  • NCT03384563 · 180 participants · Phase 4

    Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane

  • NCT03423628 · 180 participants · Phase 1

    A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05923749, the US trial registry maintained by the National Library of Medicine. NCT05923749 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.